Marcus S Noel MD
Hematologic Oncology
Medical director of the Clinical Trials Office
Join to View Full Profile
3800 Reservoir Rd NWWashington, DC 20007
Phone+1 202-444-2223
Dr. Noel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Rochester Medical CenterFellowship, Hematology and Medical Oncology, 2011 - 2014- University of Rochester Medical CenterResidency, Internal Medicine, 2008 - 2011
Rutgers Robert Wood Johnson Medical SchoolClass of 2008
Certifications & Licensure
DC State Medical License 2019 - 2026
VA State Medical License 2021 - 2026
MD State Medical License 2022 - 2025
NY State Medical License 2010 - 2020
American Board of Internal Medicine Medical Oncology
Clinical Trials
- APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers Start of enrollment: 2017 Oct 06
- A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer Start of enrollment: 2021 Mar 08
Roles: Principal Investigator
Publications & Presentations
PubMed
- TIMEPOINT, a phase 1 study combining MTL-CEBPA with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumors.Ruth Plummer, Mikael H Sodergren, Rose Hodgson, Bríd M Ryan, Nina Raulf
Cell Reports. Medicine. 2025-04-15 - A Phase 2 Study of Sotigalimab, a CD40 Agonist Antibody, plus Concurrent Chemoradiation as Neoadjuvant Therapy for Esophageal and Gastroesophageal Junction Cancers.Andrew H Ko, Joseph Chao, Marcus S Noel, Veena Shankaran, Davendra Sohal
Cancer Research Communications. 2025-02-01 - Longitudinal Circulating Tumor Cell Collection, Culture, and Characterization in Pancreatic Adenocarcinomas.Jerry Xiao, Reetu Mukherji, George Sidarous, Shravanthy Suguru, Marcus Noel
Cancers. 2025-01-22
Press Mentions
Let’s Talk About: Pancreatic Cancer’s Impact on Black AmericansFebruary 4th, 2022- ERYTECH Announces Presentation of Results of Two Clinical Trials of Eryaspase in Pancreatic Cancer at ASCO GIJanuary 24th, 2022
- ERYTECH Hosting Key Opinion Leader Webinar on Eryaspase in Pancreatic CancerAugust 24th, 2021
- Join now to see all
Grant Support
- National Capital Area (NCA) Minority/Underserved NCORPGEORGETOWN UNIVERSITY2019–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
